Skip to main content
. Author manuscript; available in PMC: 2022 Apr 15.
Published in final edited form as: Tetrahedron Lett. 2021 Feb 5;68:152896. doi: 10.1016/j.tetlet.2021.152896

Table 3.

Antimicrobial activities of compounds 1 and 2 against a suite of microorganisms.

Minimal inhibitory concentration (μg/mL)
Microorganisms 1 2 Erythromycin
E.coli >125 >125 8
S. aureus >125 >125 0.125
MRSA 63 16 >25
P. aeruginosa 125 63 32
M. smegmatis >125 >125 125
B. subtilis >125 >125 >125
B. anthracis 31 2 0.25
S. cerevisiae >125 >125 >125
C. albicans >125 >125 >125
A. niger >125 >125 >125